RecruitingDiabetesType 2 DiabetesType 2 Diabetes Mellitus - Poor Control
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.
Sponsor: Yale University
You may qualify if…
- ✓ Provision of signed and dated informed consent form
- ✓ Stated willingness to comply with all study procedures and availability for the duration of the study
- ✓ Diagnosed with type 2 diabetes mellitus
- ✓ A1c greater than or equal to 8.0 within two weeks of the time of enrollment
- ✓ On insulin for at least one year +/- other antihyperglycemics
- ✓ Ability and willingness to wear CGM for 14-day periods throughout the trial period
- ✓ Ability and willingness to comply with provider-directed adjustments to medication regimen
- ✓ Inability to afford CGM sensors
You may not qualify if…
- ✕ Insulin naïve
- ✕ Diabetic ketoacidosis (DKA) in previous 6 months
- ✕ End-Stage Renal Disease (ESRD)
- ✕ Contraindications to CGM use
- ✕ Active insurance plan that would provide enough of a subsidy for participant to feasibly purchase CGM sensors
- ✕ Pregnancy
Where it's recruiting
Connecticut
New Haven
Source: ClinicalTrials.gov · NCT06658067 · last updated 2025-12-03